Inventor
VANLANDSCHOOT PETER
BE21 patents
⚠️ This page may combine multiple inventors who share the name “VANLANDSCHOOT PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABLYNX NV
13 patentsUS10550174B2Feb 4, 2020
Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
ABLYNX NV6 citations82
US9834595B2Dec 5, 2017
Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
ABLYNX NV6 citations82
US9382333B2Jul 5, 2016
Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
ABLYNX NV3 citations72
US9803018B2Oct 31, 2017
Amino acid sequences directed against cellular receptors for viruses and bacteria
ABLYNX NV2 citations71
US9725522B2Aug 8, 2017
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
ABLYNX NV2 citations71
US9320792B2Apr 26, 2016
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
ABLYNX NV4 citations71
US10273305B2Apr 30, 2019
Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
ABLYNX NV2 citations69
US11518799B2Dec 6, 2022
Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
ABLYNX NV0 citations61
US11046773B2Jun 29, 2021
Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
ABLYNX NV0 citations59
US9822175B2Nov 21, 2017
Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
ABLYNX NV0 citations51
US9758584B2Sep 12, 2017
Biological materials related to CXCR7
ABLYNX NV0 citations49
US9994639B2Jun 12, 2018
Biological materials related to CXCR7
ABLYNX NV0 citations39
US9512236B2Dec 6, 2016
Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
ABLYNX NV0 citations38